SYNBIOTICS CORP·4

Jan 3, 4:33 PM ET

HAYS PAUL RICHARD 4

4 · SYNBIOTICS CORP · Filed Jan 3, 2005

Insider Transaction Report

Form 4
Period: 2004-12-30
HAYS PAUL RICHARD
DirectorPresident
Transactions
  • Award

    Common stock option

    [F1]
    2004-12-30+400,0002,400,000 total
    Exercise: $0.14From: 2005-03-30Exp: 2014-12-30Common Stock (400,000 underlying)
Holdings
  • Common stock

    10,653
  • Series C Preferred Stock

    [F2]
    Common Stock (778,452 underlying)
    778,452
Footnotes (2)
  • [F1]The option vests quarterly over four (4) years.
  • [F2]On September 23, 2004, Mr. Hays purchased 100 shares of Series C Convertible Preferred Stock of Synbiotics Corporation. The shares are convertible into shares of common stock at any time into such number of shares of common stock by dividing each share of Series C Convertible Preferred Stock, valued at $1,000, by the conversion price - initially set at $0.12846.
Signature
Paul R. Hays, by Keith A. Butler his attorney-in-fact|2005-01-03

Documents

1 file
  • 4
    rrd62891.xmlPrimary

    FORM 4